The Valley Desk

ArticleHeadachePublished

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Headache
Published
Subject terms
Humans; Morpholines; Piperidines; Pyridines; Treatment Outcome; Adult; Middle Aged; Cost-Benefit Analysis; Female; Male; Migraine Disorders; Calcitonin Gene-Related Peptide Receptor Antagonists
PubMed ID
39248007
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal